respiratory

Australian clinical trial register vulnerable to exploitation

Australia’s clinical trials register is at risk of being exploited by clinics advertising “pretend” trials to solicit business for expensive unproven stem cell therapies. Academics including Sydney-based pathologist and haematologist Professor John Rasko and US bioethicist Dr Leigh Turner have warned of a worldwide trend in which clinics engaging in direct-to-market advertising of unproven stem ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic